Cunha Flavia Souza, Peralta Regina Helena Saramago, Peralta José Mauro
Universidade Federal Fluminense, Faculdade de Medicina, Departamento de Patologia, Niterói, Rio de Janeiro, Brazil.
Universidade Federal do Rio de Janeiro, Instituto de Microbiologia Prof. Paulo de Góes, Rio de Janeiro, Rio de Janeiro, Brazil.
Rev Inst Med Trop Sao Paulo. 2019 Jun 19;61:e28. doi: 10.1590/S1678-9946201961028.
Cryptosporidium spp. is a pathogenic protozoan present in the gastrointestinal tract of several hosts. This protozoan was originally classified as within the Coccidia Class and has recently been reclassified to gregarine based on studies that observed the evolutionary phases from the process of excision and sequencing of the 18S rRNA gene. Molecular biology techniques have become diagnostic tools and have also been used to understand the epidemiology of Cryptosporidium spp., since several species of this genus are very similar morphologically and morphometrically. Molecular techniques have been used in the identification of parasites, at the species and subtypes levels and to study disease transmission. The laboratory diagnosis of human cryptosporidiosis can be made by parasite detection methods, such as optical microscopy, antigens or genetic material detection, as well as serum antibodies raised to Cryptosporidium spp. Molecular methods were developed and allowed, not only an extensive revision of the taxonomy, but also an improvement in the laboratory diagnosis. In Brazil, there are few reports of Cryptosporidium spp. outbreaks in humans and all of them took place in nurseries. A few epidemiological studies developed in Brazil have used molecular methods for the detection of Cryptosporidium spp., as well as genotyping studies of their species and subtypes. The use of real-time PCR, together with microscopy and immunochromatography techniques, would result in a more precise diagnosis of cryptosporidiosis. The analysis of genotypes, subtypes and clonality of Cryptosporidium could be useful to understand and define the prognosis and severity of infections.
隐孢子虫属是一种存在于多种宿主胃肠道中的致病性原生动物。这种原生动物最初被归类于球虫纲,最近基于对18S rRNA基因切除和测序过程中进化阶段的观察研究,被重新归类为簇虫。分子生物学技术已成为诊断工具,也被用于了解隐孢子虫属的流行病学,因为该属的几个物种在形态学和形态测量学上非常相似。分子技术已被用于在物种和亚型水平上鉴定寄生虫,并研究疾病传播。人类隐孢子虫病的实验室诊断可通过寄生虫检测方法进行,如光学显微镜检查、抗原或遗传物质检测,以及针对隐孢子虫属产生的血清抗体检测。分子方法的发展不仅使分类学得到了广泛修订,也改进了实验室诊断。在巴西,关于人类隐孢子虫属暴发的报道很少,且所有暴发都发生在托儿所。巴西开展的一些流行病学研究使用分子方法检测隐孢子虫属,并对其物种和亚型进行基因分型研究。将实时聚合酶链反应与显微镜检查和免疫层析技术结合使用,将能更精确地诊断隐孢子虫病。对隐孢子虫的基因型、亚型和克隆性进行分析,可能有助于了解和确定感染的预后及严重程度。